A Study Comparing The Effects Of Epoetin Hospira Single-Dose Vial (SDV) And Multi-Dose Vial (MDV) When Administered Subcutaneously To Normal Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

January 25, 2018

Primary Completion Date

April 11, 2018

Study Completion Date

May 7, 2018

Conditions
Healthy
Interventions
DRUG

Epoetin Hospira SDV

Epoetin Hospira Single Dose Vial

DRUG

Epoetin Hospira MDV

Epoetin Hospira Multi-Dose Vial

Trial Locations (1)

06511

Pfizer New Haven Clinical Research Unit, New Haven

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT03398473 - A Study Comparing The Effects Of Epoetin Hospira Single-Dose Vial (SDV) And Multi-Dose Vial (MDV) When Administered Subcutaneously To Normal Healthy Subjects | Biotech Hunter | Biotech Hunter